Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440193
Status:
COMPLETED
Last Update Posted:
2014-02-27
First Post:
2007-02-23
Brief Title:
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
11702a
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Johnson Johnson Pharmaceutical Research Development LLC | INDUSTRY |